...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: This so called “Expert Market”

"liquidation" meant to say how much more "dilution" coming are way.

Share
New Message
Please login to post a reply